Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon
Clinical trial NCT05130398 · COMPLETED
Trial details
- NCT number
- NCT05130398
- Sponsor
- Centre de Recherche Médicale de Lambaréné
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-09
- Primary completion
- 2021-09-08
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.